- Home
- PLAG vs BDRX Comparison
PLAG vs BDRX Comparison
Compare PLAG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- BDRX
- Stock Information
- Founded
- PLAG 1986
- BDRX 2000
- Country
- PLAG United States
- BDRX United Kingdom
- Employees
- PLAG N/A
- BDRX N/A
- Industry
- PLAG Packaged Foods
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- BDRX Health Care
- Exchange
- PLAG Nasdaq
- BDRX Nasdaq
- Market Cap
- PLAG 6.6M
- BDRX 5.8M
- IPO Year
- PLAG N/A
- BDRX N/A
- Fundamental
- Price
- PLAG $1.12
- BDRX $0.87
- Analyst Decision
- PLAG
- BDRX
- Analyst Count
- PLAG 0
- BDRX 0
- Target Price
- PLAG N/A
- BDRX N/A
- AVG Volume (30 Days)
- PLAG 762.3K
- BDRX 3.1M
- Earning Date
- PLAG 08-13-2025
- BDRX 04-11-2025
- Dividend Yield
- PLAG N/A
- BDRX N/A
- EPS Growth
- PLAG N/A
- BDRX N/A
- EPS
- PLAG N/A
- BDRX N/A
- Revenue
- PLAG $6,066,143.00
- BDRX N/A
- Revenue This Year
- PLAG N/A
- BDRX N/A
- Revenue Next Year
- PLAG N/A
- BDRX N/A
- P/E Ratio
- PLAG N/A
- BDRX N/A
- Revenue Growth
- PLAG N/A
- BDRX N/A
- 52 Week Low
- PLAG $0.47
- BDRX $0.78
- 52 Week High
- PLAG $5.52
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- PLAG 44.62
- BDRX 38.67
- Support Level
- PLAG $0.80
- BDRX $0.85
- Resistance Level
- PLAG $0.92
- BDRX $0.92
- Average True Range (ATR)
- PLAG 0.11
- BDRX 0.06
- MACD
- PLAG 0.02
- BDRX 0.01
- Stochastic Oscillator
- PLAG 100.00
- BDRX 32.73
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.